Physician profile
Jared R Malan
NPI 1316387665
$10,393.09
in general payments reported to CMS, 2019-2025
36 companies · $490 in 2025
The $490 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,313 · 2020: $204 · 2021: $1,797 · 2022: $4,036 · 2023: $266 · 2024: $286 · 2025: $490.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,043.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,042.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,095.52 | 2019-2025 | Allofiber, Ortholoc 3di, Augment Injectable |
| Arthrex, INC. | $2,915.52 | 2022 | |
| Alpha Orthopedic Systems | $841.18 | 2022 | |
| Medical Device Business Services, INC. | $829.48 | 2019 | |
| Paragon 28, INC. | $649.71 | 2019 | |
| Trilliant Surgical LLC. | $470.75 | 2019 | |
| Medartis INC. | $332.15 | 2019-2020 | |
| Smith+Nephew, INC. | $209.05 | 2021-2025 | Collagenase Santyl, Regranex, Iodosorb Ointment 40g USA |
| Depuy Synthes Sales INC. | $123.11 | 2019 | |
| Abbvie INC. | $90.54 | 2024-2025 | |
| Reprise Biomedical, INC. | $82.61 | 2024 | Mirotract, Miro3d, Miro3d Fibers |
| Polymedics Innovations INC. | $80.80 | 2023 | |
| Mimedx Group, INC. | $59.27 | 2024-2025 | |
| Vertex Pharmaceuticals Incorporated | $56.54 | 2025 | |
| Treace Medical Concepts, INC. | $55.87 | 2025 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $50.62 | 2020-2022 | |
| Abbott Laboratories | $45.06 | 2023 | Proclaim |
| Kerecis Limited | $42.51 | 2021-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Blue Surgical LLC | $37.05 | 2025 | |
| Ermi LLC | $35.82 | 2025 | |
| Bone Support INC. | $28.45 | 2025 | Ceramentbone Void Filler, Cerament G |
| Dynasplint Systems INC. | $26.71 | 2025 | Dynasplint |
| Integra Lifesciences Corporation | $26.58 | 2019-2020 | |
| Bsn Medical INC | $23.47 | 2022 | |
| Acera Surgical, INC. | $20.44 | 2022 | |
| Bioventus LLC | $19.88 | 2025 | Exogen Ultrasound Bone Healing System |
| Novastep INC. | $17.60 | 2021 | |
| Anika Therapeutics, INC. | $17.12 | 2022 | |
| Solventum Corporation | $15.41 | 2024 | Activ.A.C. |
| Averitas Pharma INC. | $14.75 | 2023 | Qutenza |
| Polynovo North America LLC | $14.44 | 2024 | Novosorb Btm |
| Paratek Pharmaceuticals, INC. | $14.35 | 2023 | Nuzyra |
| Organogenesis INC. | $13.73 | 2023 | Puraply |
| Kci USA, INC. | $13.23 | 2023 | Activ.A.C. |
| Kowa Pharmaceuticals America, INC. | $12.85 | 2023 | Seglentis |
| Merck Sharp & Dohme LLC | $10.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Malan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.